Answers are grounded in this paper and cite their sources.
Here we describe the case of a 51 years old Italian woman with acute lymphoblastic leukemia who underwent to hematopoietic stem cell transplantation (HSCT) during SARS-COV-2 infection. She presented a prolonged COVID-19 successfully treated with dual anti SARS-COV-2 antiviral plus monoclonal antibody therapy.
No takes yet. Share an insight, caveat, or question.
Vita et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: